Anderson, Marina E
University of Liverpool · Aintree University Hospital
3 papers on CoChatORCID 0000-0001-9073-7505
Most cited papers
- Verified
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Khanna, D., Denton, C. P., Jahreis, A., van Laar, J. M., Frech, T. M., Anderson, M. E., Baron, M., Chung, L., Fierlbeck, G., Lakshminarayanan, S., et al. (2016) · The Lancet
Systemic Sclerosis and Related DiseasesRheumatoid Arthritis Research and Therapies
Cited by 683
- Verified
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)
Khanna, D., Denton, C. P., Lin, C. J. F., van Laar, J. M., Frech, T. M., Anderson, M. E., Baron, M., Chung, L., Fierlbeck, G., Lakshminarayanan, S., et al. (2018) · Annals of the Rheumatic Diseases
Systemic Sclerosis and Related DiseasesConnective tissue disorders research
Cited by 265
- Verified
Neutrophil-derived reactive oxygen species in SSc
Barnes, T. C., Anderson, M. E., Edwards, S. W., & Moots, R. J. (2012) · Rheumatology
Systemic Sclerosis and Related DiseasesNeutrophil, Myeloperoxidase and Oxidative Mechanisms
Cited by 57
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free